Overweight volunteers help test new drug's safety and absorption
NCT ID NCT07170189
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 34 times
Summary
This early-stage study looked at how the experimental drug HU6 behaves in the bodies of 59 overweight adults. Participants took different forms (tablets or capsules) and doses of HU6, and researchers measured drug levels and checked for side effects. The goal was to gather safety and processing information, not to treat or cure any condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network
Minneapolis, Minnesota, 55114, United States
Conditions
Explore the condition pages connected to this study.